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Abstract
Homozygosity for Slc25a21tm1a(KOMP)Wtsi results in mice exhibiting orofacial abnormalities, alterations in carpal and rugae
structures, hearing impairment and inflammation in the middle ear. In humans it has been hypothesised that the 2-
oxoadipate mitochondrial carrier coded by SLC25A21 may be involved in the disease 2-oxoadipate acidaemia. Unexpectedly,
no 2-oxoadipate acidaemia-like symptoms were observed in animals homozygous for Slc25a21tm1a(KOMP)Wtsi despite
confirmation that this allele reduces Slc25a21 expression by 71.3%. To study the complete knockout, an allelic series was
generated using the loxP and FRT sites typical of a Knockout Mouse Project allele. After removal of the critical exon and
neomycin selection cassette, Slc25a21 knockout mice homozygous for the Slc25a21tm1b(KOMP)Wtsi and Slc25a21tm1d(KOMP)Wtsi
alleles were phenotypically indistinguishable from wild-type. This led us to explore the genomic environment of Slc25a21
and to discover that expression of Pax9, located 39 of the target gene, was reduced in homozygous Slc25a21tm1a(KOMP)Wtsi
mice. We hypothesize that the presence of the selection cassette is the cause of the down regulation of Pax9 observed. The
phenotypes we observed in homozygous Slc25a21tm1a(KOMP)Wtsi mice were broadly consistent with a hypomorphic Pax9
allele with the exception of otitis media and hearing impairment which may be a novel consequence of Pax9 down
regulation. We explore the ramifications associated with this particular targeted mutation and emphasise the need to
interpret phenotypes taking into consideration all potential underlying genetic mechanisms.
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Introduction
Knockout mice are invaluable tools for studying the function of
genes both during embryonic development and in the adult.
Classically, gene disruption in mice is achieved by replacing a part
of the target gene with a selectable marker, e.g. a neo cassette,
leading to constitutive ablation of the targeted gene. More
contemporary approaches include the creation of conditional
alleles and targeted gene traps, as well as small hairpin RNA
(shRNA) and the use of lentiviral transgenesis, reviewed in [1].
The Sanger Institute Mouse Genetics Project [2] is contributing to
an international effort to conduct systematic, large-scale gene
function analysis in a mammalian system, through the generation
of mice using targeted ES cells available from the EUCOMM and
KOMP resources [3]. The typical EUCOMM and KOMP
knockout first conditional ready targeted trap [tm1a(EUCOMM)
and tm1a(KOMP)] is a powerful allele configured with the
potential to convert to a conditional allele or a lacZ tagged null
allele [3]. This tm1a allele was selected for pragmatic reasons,
including there being no requirement for additional breeding to
modify the allele, as targeted traps typically disrupt expression of
the targeted gene [3,4], and the major advantage that the allele,
with full potential for conversion, would be cryopreserved for
subsequent community use. However, it has previously been
reported that the presence of selectable markers used for gene
targeting, such as the neo cassette in the EUCOMM and KOMP
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tm1a allele, can interfere with the expression of neighbouring
genes [5,6,7,8,9]. It is, therefore, important that phenotypes
discovered in mice carrying the knockout first conditional ready
allele, are verified using the derived deletion allele.
SLC25A21 has previously been reported to be ubiquitously
expressed in all tissues tested [10], and codes for the 2-oxoadipate
mitochondrial carrier (ODC) that catalyses the movement of
several substrates, primarily 2-oxoadipate and 2-oxoglutarate,
across inner mitochondrial membranes [10,11,12]. It is suspected
that ODC functions by a counter exchange mechanism, catalysing
the uptake of 2-oxoadipate into the mitochondrial matrix, in
exchange for internal 2-oxoglutarate [10]. The physiological role
of the ODC suggests that it may be involved in the human disease
2-oxoadipate acidaemia (OMIM 204750), characterised by an
accumulation of 2-oxoadipate and associated metabolites in urine
[11]. This inborn error of metabolism shows clinical symptoms of
intellectual disability varying from mild to severe, hypotonia,
seizures, motor and developmental delay, and cerebellar ataxia
[13,14,15,16].
Here we report characterization of the allelic series derived from
the KOMP targeted allele of Slc25a21. From this, three distinct
observations were made. Firstly, ablation of Slc25a21 was not
found to cause symptoms of 2-oxoadipate acidaemia in mice;
animals homozygous for Slc25a21tm1b(KOMP)Wtsi and Slc25a21tm1d(-
KOMP)Wtsi null alleles were normal for all parameters tested.
Secondly, we report that Slc25a21tm1a(KOMP)Wtsi homozygous mice
present with profound dental, orofacial and hearing/middle ear
phenotypes caused by off-target effects on the expression of the
neighbouring gene Pax9. Finally, the resulting novel, hypomorphic
allele of Pax9 opens the door to further studies into how Pax9 is
involved in the patterning of the palatal rugae and may represent a
novel model of otitis media in the mouse. With the growing
resource of knockout first conditional ready targeted ES cells
created by the EUCOMM and KOMP initiatives, these results
represent a timely reminder that the phenotype observed in the
knockout first conditional ready mice should be verified by
creating and analysing the deletion allele.
Materials and Methods
Ethics Statement
The care and use of all mice in this study were in accordance
with UK Home Office regulations, UK Animals (Scientific
Procedures) Act of 1986, and were approved by the Wellcome
Trust Sanger Institute Ethical Review Committee. All efforts were
made to minimize suffering including housing mice in a specific
pathogen-free unit at a density of 3–5 animals per cage in
polysulfone individually ventilated cages [Tecniplast Seal Safe
1284L (overall dimensions of caging: (L6W6H):
36562076140 mm, floor area = 530 cm2)]. Sterilised Aspen
bedding substrate and standard environmental enrichment of
nestlet, cardboard tunnel, and three wooden chew blocks were
provided. The light cycle was maintained at 12 h light/12 h dark
with lights off at 19:30 hours and no twilight period. Room
temperature was 2162uC and humidity was regulated at
55610%. Mice were given food and water ad libitum unless
otherwise stated [2]. Animal welfare is our primary consideration
and was assessed routinely for all mice involved in this study. Adult
mice were killed by terminal anaesthesia followed by exsanguina-
tion and either cervical dislocation or removal of the heart.
Embryos were killed by decapitation or cooling followed by
immersion in cold tissue fixative. Experimental work was
performed in accordance with the Arrive guidelines [17].
Animals
The Slc25a21tm1a(KOMP)Wtsi mice were created by blastocyst
injection of targeted ES-cell clone EPD0085_1_D04 from the
NIH-funded Knockout Mouse Project (KOMP) [3,18,19]. Gen-
eration of mice carrying the Slc25a21tm1b(KOMP)Wtsi, Slc25a21tm1c(K-
OMP)Wtsi and Slc25a21tm1d(KOMP)Wtsi alleles was achieved by breed-
ing to mice expressing Cre (Hprt1Tg(CMV-Cre)Brd) and/or Flp
(ROSA26Fki) recombinases. For brevity, the allelic series will be
referred to hereafter in figures as tm1a, tm1b, tm1c or tm1d. The
Slc25a21tm1a(KOMP)Wtsi, Slc25a21tm1b(KOMP)Wtsi, Slc25a21tm1c(KOMP)Wtsi
and Slc25a21tm1d(KOMP)Wtsi colonies were maintained on a C57BL/
6N;C57BL/6-Tyrc-Brd genetic background.
Mice were fed Mouse Breeders Diet (Lab Diets 5021-3,
Richmond, Indiana, USA) unless otherwise specified, including
Slc25a21tm1d(KOMP)Wtsi mice processed through the Mouse Genetics
Project screening protocol [2]. Slc25a21tm1a(KOMP)Wtsi, Slc25a21tm1b(-
KOMP)Wtsi and Slc25a21tm1c(KOMP)Wtsi mice which went through the
Mouse Genetics Project screening protocol were transferred to a
high-fat (21.4% fat by crude content) dietary challenge (Special
Diet Services Western RD-829100, Witham, UK) at 4 weeks of
age. Cages were processed randomly and different genotypes
could be housed together, hence there was no pattern to the order
in which animals were processed. The experimental unit
throughout the study was a single mouse.
Viability at postnatal day 14 was assessed from heterozygous
(het) intercross matings. Furthermore, viability and embryo
morphology for Slc25a21tm1a(KOMP)Wtsi mutant mice was assessed
at E14.5 and E18.5.
Validation of targeting event
To confirm the integrity and validity of each allele studied,
detailed molecular characterisation was performed using short-
range, long-range and quantitative PCR strategies, as described
previously [20] and detailed in File S1 and Table S1.
Genotyping for Slc25a21tm1a(KOMP)Wtsi animals was performed
using a combination of three short range assays (Table S1) and the
neo count qPCR assay (0 = wt, 1 = het, 2 = hom). Conversion to
Slc25a21tm1b(KOMP)Wtsi, Slc25a21tm1c(KOMP)Wtsi and Slc25a21tm1d(-
KOMP)Wtsi was detected using short range PCR assays (Table S1).
Work by Santagati [21] indicated the presence of a regulatory
element, named conserved non-coding sequence +6 (CNS+6), for
Pax9 within the allele design for Slc25a21tm1a(KOMP)Wtsi. A PCR
assay was designed (Table S1) to amplify Slc25a21tm1a(KOMP)Wtsi
samples and the resulting products sequenced to determine if the
CNS+6 element was disrupted.
Expression analysis by quantitative PCR and RNA
sequencing
E13.5 embryo heads [Slc25a21tm1a(KOMP)Wtsi (wt, n = 4; hom,
n = 4), Slc25a21tm1b(KOMP)Wtsi (wt, n = 4; hom, n = 3), Slc25a21tm1c(K-
OMP)Wtsi (wt, n = 4; hom, n = 3), and Slc25a21tm1d(KOMP)Wtsi (wt,
n = 4; hom, n = 3)] were processed for expression analysis by
qPCR. For Slc25a21 a custom FAM-labelled TaqMan assay
(Applied Biosystems) spanning the junction of exons 8–9, 39 to the
floxed exon (Slc25a21_E8-9_F: CTGCTTCAAAACAATGGA-
GATGAT, Slc25a21_E8-9_R: GGGACCAGGCCTTTGTA-
TAAGG, Slc25a21_E8-9_M: CGGGAAGAAGGGATTT) was
used. For Pax9 a pre-designed TaqMan assay was used
(Mm00440629_m1, Applied Biosystems). Details of the assays
and methods used are described in File S1.
RNA sequencing was performed using 5 mg of total RNA from
a subset of the above E13.5 embryo head samples [3 homozygotes
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and 2 wild-types for each allele (12 mutant and 8 control samples
in total)] as detailed in File S1.
Physical assessment, body composition, radiography and
clinical chemistry
Homozygous mice (7M and 7F) from each of the alleles
(Slc25a21tm1a(KOMP)Wtsi, Slc25a21tm1b(KOMP)Wtsi, Slc25a21tm1c(K-
OMP)Wtsi and Slc25a21tm1d(KOMP)Wtsi), as well as age, sex and genetic
background matched controls, were analysed using the standard
Sanger Institute Mouse Genetics Project phenotyping screen [2].
Assays of particular relevance are described in File S1, whilst those
not part of the standard phenotyping screen are described below.
At necropsy, skulls were collected and the teeth (both upper and
lower jaw) and palate were reviewed and imaged (MZ16A
dissecting microscope, Leica, Wetzlar, Germany; DFC490 digital
camera, Canon Powershot G5, Japan). A range of 42 additional
tissues and organs from homozygous Slc25a21tm1a(KOMP)Wtsi mice
(2M and 2F), and age, sex and genetic background matched
controls, were fixed in 10% neutral buffered formalin (Leica
Biosystems, Peterborough, UK) for 15–20 hrs and processed to
wax. 5 mm sections were stained with haematoxylin and eosin then
reviewed by an experienced pathologist.
Micro-CT (computed tomography) images of skulls from
Slc25a21tm1a(KOMP)Wtsi mice (wt, n = 2; hom, n = 2) were collected
at 18 mm resolution (SkyScan 1176, SkyScan, Kontich, Belgium).
Auditory Brainstem Response (ABR) recordings
ABRs were recorded in Slc25a21tm1a(KOMP)Wtsi mice aged 4
weeks (wt, n = 17; het, n = 27; hom, n = 7), 8 weeks (wt, n = 20; het,
n = 33; hom, n = 8), 14 weeks (wt, n = 11; hom, n = 14), and 26
weeks (wt, n = 17; hom, n = 10), using the methods described in
detail in Ingham et al. [22]. In addition, mice from the
Slc25a21tm1b(KOMP)Wtsi colony (hom, n = 8), Slc25a21tm1c(KOMP)Wtsi
colony (hom, n = 5) and Slc25a21tm1d (KOMP)Wtsi colony (hom, n = 8)
were tested at 14 weeks of age.
Anaesthetised mice were placed on a heating blanket inside a
sound attenuating booth and recording electrodes inserted in the
skin to record responses of the left ear. For ABR threshold
determination, click (0.01 ms duration) and tone pip (6, 12, 18, 24,
and 30 kHz of 5 ms duration, 1 ms rise/fall time) stimuli over a
range of intensity levels from 10–95 dB sound pressure level (SPL)
in 5 dB steps were presented in free-field. Averaged responses to
256 stimuli, presented at 42.2/s, were analysed and thresholds
established as the lowest sound intensity giving a visually-
detectable ABR response.
Middle ear analysis
Following ABR testing, Slc25a21tm1a(KOMP)Wtsi mice aged 9 weeks
(wt, n = 8; het, n = 11; hom, n = 8) were killed by cervical
dislocation and the right external and middle ears were examined
in detail using a dissecting microscope for any signs of
malformation or inflammation, including: appearance of excess
cerumen in the external ear canal; thickening, whitening,
sponginess or excess vascularisation of the bulla wall; clarity and
vascularisation of the tympanic membrane; presence of fluid or
white inflammatory material in the middle ear cavity; and solid
masses or bony outgrowths of the middle ear wall or ossicles. In
addition, the left side of the head of these mice was fixed in 10%
formalin for 48 hours, and decalcified in 10% EDTA diluted in
phosphate buffered saline (PBS) for 10 days, dehydrated,
embedded in paraffin wax, sectioned at 8 mm and stained with
haematoxylin and eosin.
Reporter gene analysis
LacZ reporter gene wholemount expression analysis was
performed on Slc25a21tm1a(KOMP)Wtsi adults [aged 15–18 weeks
(wt, n = 2; het, n = 3; hom, n = 9)] as described previously [23] and
detailed in File S1.
Bone and cartilage staining
Bone and cartilage staining of Slc25a21tm1a(KOMP)Wtsi E18.5
embryos (wt, n = 10; het, n = 27; hom, n = 12) was performed
using a protocol based on the Cold Spring Harbour method for
Alcian blue/Alizarin Red staining [24], and detailed in File S1.
Data analysis and statistics
A reference range approach was used to assess continuous data,
including time course. For categorical data, a Fisher’s exact test
was used to identify phenotypic variants. More details of both
approaches are presented in File S1. Since both of the above
approaches to automatically identify significant calls are known to
be conservative and assess each parameter in isolation, they were
complemented by a manual assessment made by a biological
expert who used knowledge of events on the day, or across sexes,
or between related variables, to highlight additional potentially
abnormal phenotypes (Table S2).
To assess the ABR data, a one-way Kruskall-Wallis ANOVA on
Ranks was used where three genotypes were assessed and Mann-
Whitney rank sum test where only homozygote and wild-type
animals were assessed. The qPCR gene expression results for
mutant mice were compared to littermate wild-type mice using a
Student’s t-Test assuming two-sample unequal variance. P-values
for the RNA sequencing were adjusted for multiple testing with the
Benjamini-Hochberg procedure. Pre-weaning lethality was assess-
ed using the Test for One Proportion.
Results
Characterisation of Slc25a21tm1a(KOMP)Wtsi homozygous
mice
Slc25a21tm1a(KOMP)Wtsi mice were generated and characterised on
a C57BL/6N;C57BL/6-Tyrc-Brd background by the Sanger Mouse
Genetics Project. Homozygous Slc25a21tm1a(KOMP)Wtsi mice were
under-represented at post natal day 14 (P14), as a result of pre-
weaning lethality, with 25 homozygous mutants detected among
304 progeny from heterozygous intercrosses (Table 1. Test for one
proportion; x2 = 44.74, df = 1, p = 1.124e-11).
Those homozygous animals surviving to weaning, presented
with decreased body weight (Fig. 1A–B), fat mass (Fig. 1C–D) and
fat percentage estimate (data not shown), in both sexes, compared
to wild-type controls. Furthermore, a range of dental abnormal-
ities were observed in Slc25a21tm1a(KOMP)Wtsi homozygous mice. At
10 weeks of age 13 out of 14 homozygous Slc25a21tm1a(KOMP)Wtsi
mice were found to have an abnormally shortened snout (data not
shown). At 16 weeks of age all fourteen homozygous Slc25a21t-
m1a(KOMP)Wtsi mice were found to have macroscopically visible
dental abnormalities ranging from white or translucent to severely
hypoplastic lower incisors (Fig. 2A–B) compared to wild-type
(Fig. 2C). The molars of homozygous Slc25a21tm1a(KOMP)Wtsi adult
mice (Fig. 2D), in particular of the lower jaw, were found to be
strongly stained with X-gal (requiring b-galactosidase activity)
compared to heterozygous and wild-type (Fig. 2E–F). Microscopic
examination of sections from representative animals confirmed
that in unaffected areas, the molars were fully developed with
normal odontoblast morphology. In affected areas of the molars,
there was focal fracturing of the surface dentine and necrosis of the
pulp with associated inflammation and bacterial colonies (Fig. 2G).
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Micro-CT scanning revealed that the lower incisor root area in
homozygous Slc25a21tm1a(KOMP)Wtsi mice was severely under-
developed and that the lower incisors appeared to be lacking the
enamel coating (Fig. 2H–I) compared to wild-type (Fig. 2J).
Furthermore, two dimensional X-ray images revealed several
changes of the manidibular morphology including pronounced
pogonion, pronounced anterior tuberosity, under-developed inci-
sor process and alveolus (data not shown), potentially indicating a
change in the developmental dynamics of the mandible in
homozygous Slc25a21tm1a(KOMP)Wtsi mice. Taken together, the 2D
X-ray images, micro-CT and X-gal staining in tooth cavities
suggests feeding might be uncomfortable for homozygous
Slc25a21tm1a(KOMP)Wtsi mice which may explain their reduced body
weight and fat mass.
Further characterisation uncovered craniofacial abnormalities
in adult homozygous Slc25a21tm1a(KOMP)Wtsi mice. Specifically, they
presented with abnormal development of palatal rugae number 3
(Fig. 3A–C) compared to wild-type (Fig. 3D). Micro-CT scanning
revealed that the anterior part of the vomer bone was completely
absent in homozygous Slc25a21tm1a(KOMP)Wtsi mice (Fig. 3E–F)
compared to wild-type (Fig. 3G), this was confirmed by
macroscopic observations (Fig. 3H). The vomeronasal organ
(VNO) appeared to be intact. Morphological examination of
E18.5 embryo heads from homozygous Slc25a21tm1a(KOMP)Wtsi mice
did not reveal any further craniofacial abnormalities.
Finally, 14 week old Slc25a21tm1a(KOMP)Wtsi homozygous mice
were found to have a hearing impairment as they presented with
elevated auditory brainstem response thresholds across all
frequencies, with severity of impairment increasing with age
(Fig. 4A–D). Slc25a21tm1a(KOMP)Wtsi homozygous mice displayed an
approximately parallel pattern of threshold elevation across the
range of frequency stimuli used, a profile which is typical of
conductive hearing loss. Fig. 4E shows that click threshold in wild-
types was stable with increasing age, at least up to 26 weeks of age,
whereas a progressive deterioration was seen in Slc25a21tm1a(-
KOMP)Wtsi homozygous mice over the same age range. At 26 weeks
of age, some wild-type mice showed age-related high-frequency
hearing loss (indicated by larger standard deviations at 24–
30 kHz). The thresholds recorded in the Slc25a21tm1a(KOMP)Wtsi
homozygous mice at all ages were significantly elevated above age-
matched wild-types (p,0.001) (Fig. 4F).
To investigate the morphology of the middle ear, the right
temporal bone, containing the entire ear, was dissected from
Slc25a21tm1a(KOMP)Wtsi homozygous mice at 9 weeks of age (n = 8)
along with wild-type (n = 8) and heterozygous (n = 11) littermates.
Compared to wild-types (Fig. 5A), most of the homozygotes (7/8)
showed opaque fluid or white debris in the middle ear cavity
indicating otitis media (Fig. 5B). Other features of otitis media
were more variable, including excessive vascularisation (n = 3) or
whitening of the bulla (n = 4) or tympanic membrane (n = 1). The
one homozygous Slc25a21tm1a(KOMP)Wtsi mouse in which exudate
was not observed in the middle ear also had ABR thresholds only
slightly above those seen in wild-type mice. Heterozygotes had
normal middle ears.
The left side temporal bones from the same eight Slc25a21tm1a(-
KOMP)Wtsi homozygous mice and wild-type controls were sectioned
through the middle ear, stained with haemotoxylin and eosin, and
examined microscopically. Inflammatory changes and accumula-
tion of exudate consistent with otitis media were observed in six of
the eight homozygotes (Fig. 5D, F).
The middle ear cavity of the six affected Slc25a21tm1a(KOMP)Wtsi
homozygous mice contained variable amounts of an amorphous
eosinophilic exudate containing cholesterol crystals, foamy mac-
rophages and neutrophils, indicating an active inflammatory
response. In these mice, the lining epithelium of the middle ear
cavity was variably hyperplastic and the underlying lamina propria
was oedematous with congestion of blood vessels (Fig. 5D, F).
None of the littermate controls showed evidence of inflammation
(Fig. 5A, C, E).
Of the two Slc25a21tm1a(KOMP)Wtsi homozygous mice showing
little or no effusion one had comparatively normal ABR
thresholds, whilst the other had raised ABR thresholds.
The tympanic ring size was normal in Slc25a21tm1a(KOMP)Wtsi
homozygous mice; assessment of micro-CT images revealed no
change in adults whilst alizarin red/alcian blue stained embryos
revealed no changes at E18.5 (data not shown).
Systematic histopathology assessment of a range of tissues from
homozygous Slc25a21tm1a(KOMP)Wtsi mice did not reveal any further
abnormalities, and in particular, no indication of any inflamma-
tion other than in the middle ear was found.
Ablation of Slc25a21 does not cause signs of 2-
oxoadipate acidaemia in mice
It has been proposed that loss of function of ODC, the protein
encoded by SLC25A21, causes the human disease 2-oxoadipate
acidaemia which is clinically characterised by hypotonia, seizures,
motor and developmental delay, cerebellar ataxia and varying
severities of intellectual disability [13,14,15,16]. Unexpectedly,
homozygous Slc25a21tm1a(KOMP)Wtsi mice did not phenocopy this
human disease. In particular, lean mass, grip strength and gait,
correlates of the human disease manifestation, were all normal for
these mice (data not shown), and no seizures were detected.






types Number of Heterozygotes Number of Homozygotes
Percentage Homozygote
Viability
tm1a E14.5 35 3 22 8 23%
tm1a E18.5 44 10 27 7 16%
tm1a P14 304 111 168 25 8%
tm1b P14 130 24 68 38 29%
tm1c P14 145 26 84 35 24%
tm1d P14 193 44 113 36 19%
From heterozygous inter-crossing, homozygous progeny for Slc25a21tm1a(KOMP)Wtsi were recorded at a sub-Mendelian ratio at post natal day 14 (P14), but a normal ratio
at two embryonic time points (E14.5 and E18.5). Slc25a21tm1b(KOMP)Wtsi, Slc25a21tm1c(KOMP)Wtsi and Slc25a21tm1d(KOMP)Wtsi homozygotes were detected at the expected
ratio.
doi:10.1371/journal.pone.0091807.t001
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To ascertain the molecular consequence of the targeting event,
expression analysis of Slc25a21tm1a(KOMP)Wtsi was performed on
RNA extracted from embryo heads (E13.5). When using the
Slc25a21 TaqMan assay which spanned exons 8–9, 39 of the
cassette insertion, expression was found to be reduced in
homozygous Slc25a21tm1a(KOMP)Wtsi samples (28.7% of wild-type
expression, p = 2.0e-05) but not completely ablated (Fig. 6A). The
hypomorphic nature of this allele may have explained the absence
of the predicted phenotypes, therefore an allelic series was created
(Fig. 6B–E) where tm1b was a lacZ reporter tagged deletion with
the critical exon (exon 4) removed, tm1c a conditional allele with
wild-type function restored, and tm1d the deletion allele where
both exon 4 and the lacZ reporter were removed. Expression
analysis of each of these Slc25a21 alleles was performed on RNA
extracted from embryo heads (E13.5). Slc25a21 RNA expression
was found to be ablated in homozygous Slc25a21tm1b(KOMP)Wtsi (0%
of wild-type expression, expression was below the limit of
detection) and greatly reduced in Slc25a21tm1d(KOMP)Wtsi homozy-
gotes (12.9% of wild-type expression, p = 0.043) (Fig. 6A). As
expected, expression levels of Slc25a21 in embryos homozygous for
Slc25a21tm1c(KOMP)Wtsi were not significantly different from wild-
type expression (Fig. 6A).
We proceeded by phenotyping animals homozygous for the
Slc25a21tm1b(KOMP)Wtsi, Slc25a21tm1c(KOMP)Wtsi and Slc25a21tm1d(-
KOMP)Wtsi alleles. Following heterozygous intercrossing, homozy-
gous animals for all three alleles were detected at the expected
Mendelian ratio. Furthermore, body weight, fat mass and auditory
brainstem response thresholds (Mann-Whitney Rank Sum Tests;
tm1b, p = 0.12; tm1c, p = 0.48; tm1d, p = 0.59) (Fig. 7A–I) were all
found to be normal compared with wild-types, as were the teeth
and palatal rugae (data not shown). Full data from the
phenotyping pipeline can be viewed online (www.sanger.ac.uk/
mouseportal).
These results led us to conclude that the phenotypes observed in
mice homozygous for the Slc25a21tm1a(KOMP)Wtsi targeted allele
were not due to ablation of Slc25a21 function, and speculate that
off-target effects due to the selection cassette present in the tm1a
allele affected expression of neighbouring genes.
Figure 1. Body weight and fat mass were reduced in homozygous Slc25a21tm1a(KOMP)Wtsi mice. Homozygous (red symbols)
Slc25a21tm1a(KOMP)Wtsi female (A,C) (n = 7) and male (B,D) (n = 7) mice showed decreased body weight and fat mass compared to local wild-type
controls run on the same week (green symbols) (female, n = 22; male, n = 15). Mean (6 SD) body weight is plotted against age (A,B). Fat mass is
presented as a boxplot, with median, 25th and 75th percentile (box), and the lowest and highest data point within 1.56 inter quartile range (whiskers)
shown (C,D). The median and 95% reference range (2.5–97.5th percentiles, dotted lines) for all wild-type mice of the same genetic background and
sex (n.750) are displayed on the pale green background.
doi:10.1371/journal.pone.0091807.g001
Slc25a21 Targeting Alters Adjacent Gene Expression
PLOS ONE | www.plosone.org 5 March 2014 | Volume 9 | Issue 3 | e91807
Hypomorphic expression of Pax9 may account for
observed phenotypes
The 1 Mb genomic interval containing Slc25a21 (500 kb
flanking the target gene) is predicted to contain seven known
protein coding genes, one non coding RNA, one novel antisense
and one putative processed transcript (Fig. S1). Of particular
interest is Pax9, located at the 39 end of Slc25a21 and orientated on
the opposite strand. The 39UTR regions of Slc25a21 and Pax9
overlap by 188 bp. Consistent with the phenotypes observed in
Slc25a21tm1a(KOMP)Wtsi homozygous animals, mice carrying a
hypomorphic Pax9 allele had previously been reported as causing
reduced viability at weaning [25], and presented with a range of
dental and craniofacial abnormalities [25,26] similar to those
described herein.
RNA expression analysis of Pax9 was performed on embryo
heads (E13.5) for all four alleles in the Slc25a21 series. Pax9
expression was found to be down regulated [approximately 34% of
wild-type Pax9 levels (p = 1.1E-06)] in homozygous Slc25a21tm1a(-
KOMP)Wtsi samples (Fig. 8) confirming our hypothesis that we had
inadvertently created a Pax9 hypomorphic allele. Pax9 levels were
found to be unaffected in homozygous Slc25a21tm1b(KOMP)Wtsi,
Slc25a21tm1c(KOMP)Wtsi and Slc25a21tm1d(KOMP)Wtsi samples (Fig. 8). A
known Pax9 regulatory element (CNS+6) was located within the
targeting construct used to create the Slc25a21tm1a(KOMP)Wtsi allele
[21]. PCR and sequence analysis was used to demonstrate that this
sequence was not disrupted during the vector construction or at
the homologous recombination stage (Table S1; data not shown).
Consequently, we hypothesise that the presence of the promoter
driven neomycin cassette in the homozygous Slc25a21tm1a(KOMP)Wtsi
mice caused the reduction of Pax9 expression.
RNA sequencing was performed to further explore the impact
of the targeting event on the genomic environment around
Slc25a21. Comparing RNA from wild-type and homozygous
Slc25a21tm1a(KOMP)Wtsi E13.5 embryo heads, the only gene in the
1 Mb interval surrounding Slc25a21 that had significantly altered
expression levels was Pax9 [q (adjusted p value) = 7.10E-06 (data
not shown)]. Pax9 was not found to be differentially expressed in
homozygous Slc25a21tm1b(KOMP)Wtsi, Slc25a21tm1c(KOMP)Wtsi and
Slc25a21tm1d(KOMP)Wtsi embryo heads. The low endogenous expres-
sion level of Slc25a21 in wild-type mice was below the threshold
where significant changes could be detected.
The phenotypes we observed in homozygous Slc25a21tm1a(-
KOMP)Wtsi mice were broadly consistent with those reported
previously in mice carrying hypomorphic Pax9 alleles [26] with
the exception that the otitis media and hearing impairment
reported in this study have not been assessed previously in Pax9
mutant mice and may represent a novel consequence of Pax9
suppression.
Discussion
Characteristics of 2-oxoadipate acidaemia are absent in
mice ablated for Slc25a21 expression
We report the generation and phenotypic characterisation of
the Slc25a21 allelic series derived from a typical KOMP-CSD
allele [3]. Subject to the sensitivity and scope of the phenotyping
performed, ablation of Slc25a21 expression was not found to
phenocopy the human disease 2-oxoadipate acidaemia (OMIM
204750) for which it is a candidate gene [11]. There are several
possible explanations for this. Whilst no hypotonia, ataxia or
seizures were detected in Slc25a21 null mice [homozygous for the
tm1b (KOMP)Wtsi or tm1d (KOMP)Wtsi alleles], a subset of
other clinical symptoms associated with 2-oxoadipate acidaemia,
including intellectual disability and urine metabolites, were not
assessed by the standard Mouse Genetics Project primary
phenotyping pipeline with which these animals were screened
[2]. Therefore it cannot be ruled out that additional tests, or
analysis performed with increased sensitivity, may reveal subtle
disease similarities. Alternatively, mitochondrial transport of
metabolites is a complex process involving many carrier proteins.
Unknown compensatory mechanisms may be at play in Slc25a21
null mice that prevent the cytoplasmic build-up of oxoadipate and
the associated disruption in the catabolism of key amino acids such
as lysine [11]. For example, it is known that the substrate
specificity of Slc25a21 itself varies between species [11]. Finally,
Figure 2. Dental abnormalities observed in homozygous
Slc25a21tm1a(KOMP)Wtsi mice. Dysmorphology analysis revealed under-
developed, white incisors (A–B) in Slc25a21tm1a(KOMP)Wtsi homozygous
mice as compared to wild-type (C). Wholemount (D–F) and subsequent
histological sections (G) demonstrated bacterial lacZ activity in cavities
within lower jaw molars of Slc25a21tm1a(KOMP)Wtsi homozygous (D,G)
mice compared to heterozygous (E) and wild-type (F) mice. Focal
fracturing of the surface dentine is indicated with a black arrow and
necrosis of the pulp indicated with a red arrow (G). Micro-CT imaging
demonstrated that the root aspect of lower jaw incisors was severely
under developed (white arrow) and lacked enamel coating in
homozygous Slc25a21tm1a(KOMP)Wtsi mice (H–I) compared to wild-type
(J).
doi:10.1371/journal.pone.0091807.g002
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Figure 3. Rugae and vomer abnormalities observed in homozygous Slc25a21tm1a(KOMP)Wtsi mice. Abnormalities in rugae (in particular
number 3) were observed in homozygous Slc25a21tm1a(KOMP)Wtsi mice (A–C) compared to wild-type (D), indicated with arrows (wt, n = 11; hom, n = 11).
Micro-CT analysis revealed that the anterior part of the vomer bone was absent in Slc25a21tm1a(KOMP)Wtsi homozygous mice (E–F) compared to wild-
type (G) (wt, n = 2; hom, n = 12). This was confirmed by dissection of the palate of Slc25a21tm1a(KOMP)Wtsi mice (H).
doi:10.1371/journal.pone.0091807.g003
Figure 4. Auditory brainstem response threshold was elevated in Slc25a21tm1a(KOMP)Wtsi mice. Auditory brainstem response threshold was
elevated across all frequencies in homozygous Slc25a21tm1a(KOMP)Wtsi mice aged 1, 2, 3 and 6 months respectively. Mean ABR thresholds (6 SD) are
shown for wild-type (green symbols), heterozygote (blue symbols) and homozygote (red symbols) Slc25a21tm1a(KOMP)Wtsi mice (A–D). The click-evoked
ABR thresholds (mean 6 SD) plotted as a function of age (months) demonstrated a progressive deterioration in Slc25a21tm1a(KOMP)Wtsi mice (E); an
observation clearly demonstrated by plotting the mean click-evoked ABR threshold elevation of mutants above wild-types as a function of age
(months) (F).
doi:10.1371/journal.pone.0091807.g004
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definitive proof of the candidacy of Slc25a21 for 2-oxoadipate
acidaemia is not published and it has been speculated that the
disease may be due to defective 2-oxoadipate dehydrogenase, an
alternative gene in the same metabolic pathway [11].
Slc25a21tm1a(KOMP)Wtsi allele affects expression of a
neighbouring gene
The Slc25a21tm1a(KOMP)Wtsi homozygous mice investigated in this
study were found to be sub-viable. Those homozygous animals
surviving to weaning presented with growth retardation, orofacial
abnormalities, brittle, white incisors and hearing impairment.
Given the absence of any detectable phenotype in mice
homozygous for the Slc25a21 tm1b (KOMP)Wtsi, tm1c
(KOMP)Wtsi or tm1d (KOMP)Wtsi derived alleles, we conclude
that the phenotypes observed in mice homozygous for Slc25a21t-
m1a(KOMP)Wtsi were not due to ablation of Slc25a21 function, and
propose that off-target effects of the tm1a allele affected expression
of a neighbouring gene. The spatial, temporal and quantitatively
correct activity of a gene requires the presence of not only intact
coding sequence but also properly functioning regulatory control.
Figure 5. Signs of otitis media in Slc25a21tm1a(KOMP)Wtsi mice. The tympanic membrane viewed from the external ear canal showed an opaque
fluid present in Slc25a21tm1a(KOMP)Wtsi homozygous mice (B) that was not present in wild-type controls (A). The opaque exudate was clearly visible on
haematoxylin and eosin stained histology sections through the middle ear of Slc25a21tm1a(KOMP)Wtsi homozygous mice (D) compared to wild-types (C).
Examination at higher magnification revealed that the exudate containing inflammatory cells including foamy macrophages (solid arrow head), and
neutrophils (short arrow) in the middle ear cavity (MEC), and a thickened mucosa (M, double headed arrow) in Slc25a21tm1a(KOMP)Wtsi homozygous
mice due to epithelial hyperplasia, oedema and congestion (F). Wild-type mice appeared normal (E).
doi:10.1371/journal.pone.0091807.g005
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Interference of the expression of neighbouring genes by the
presence of selectable marker cassettes or short DNA sequences
[5,6,7,8,9] has been reported for genes in close vicinity to the
target gene and as far as .100 kb from the targeted gene [6].
Transcriptional silencing of neighbouring genes due to CpG rich
sequences within the standard, non-codon optimised, lacZ reporter
gene used in this KOMP-CSD allele has also been reported [27].
Furthermore, disruption of cis-regulatory elements has been linked
with abnormal phenotypes in both mice [5] and humans [28,29].
In addition, a wide variety of mechanisms which cause disruption
of gene expression by a change in its chromosomal environment,
while leaving the transcription unit intact, have been identified
[29].
At E13.5, RNA sequencing revealed that the only gene within
the 1 Mb genomic interval surrounding Slc25a21 that was
differentially expressed, compared to wild-type, in homozygous
Slc25a21tm1a(KOMP)Wtsi embryos was Pax9, an observation con-
firmed by quantitative PCR. Pax9 is located in a 21.06 kb genomic
interval directly 39 of Slc25a21 and orientated on the opposite
strand. Evolutionarily conserved non-coding sequences are present
both up-and down-stream of Pax9, some of which have been
demonstrated to induce Pax9 expression [21]. One such conserved
region, CNS+6, [21] was located within the homology arm of the
Slc25a21tm1a(KOMP)Wtsi targeting construct, and therefore a candi-
date for causing altered Pax9 expression. However, sequencing
confirmed the integrity of CNS+6 in the Slc25a21tm1a(KOMP)Wtsi
allele. Since homozygous Slc25a21tm1b(KOMP)Wtsi mice, which still
Figure 6. Schematic of the Slc25a21tm1(KOMP)Wtsi allelic series and the associated RNA expression levels. Quantitative PCR on RNA from
E13.5 embryo heads demonstrated that Slc25a21 RNA expression was significantly reduced in Slc25a21tm1a(KOMP)Wtsi, Slc25a21tm1b(KOMP)Wtsi and
Slc25a21tm1d(KOMP)Wtsi homozygotes (* p,0.05; *** p,0.001), but equivalent to wild-type levels in Slc25a21tm1c(KOMP)Wtsi homozygotes (A). A schematic
of the Slc25a21tm1(KOMP)Wtsi allelic series is presented, consisting of: (B) Slc25a21tm1a(KOMP)Wtsi, the knockout first reporter (lacZ) tagged insertion allele;
(C) Slc25a21tm1b(KOMP)Wtsi, the lacZ tagged deletion allele generated by breeding with mice ubiquitously expressing Cre recombinase; (D)
Slc25a21tm1c(KOMP)Wtsi, the conditional allele generated by breeding mice carrying the Slc25a21tm1a(KOMP)Wtsi allele with mice ubiquitously expressing
Flp recombinase; and (E) Slc25a21tm1d(KOMP)Wtsi, the deletion allele arising after breeding mice carrying the Slc25a21tm1c(KOMP)Wtsi allele with mice
ubiquitously expressing Cre recombinase (E).
doi:10.1371/journal.pone.0091807.g006
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have part of the targeting cassette present (Fig. 6C), were found to
be phenotypically normal, interference by the polyA-b-actin::neo
cassette is the most likely cause of the reduction of Pax9 expression
seen in homozygous Slc25a21tm1a(KOMP)Wtsi mice. The findings in
this study highlight the need to confirm phenotypes found in
animals carrying the knockout first conditional ready [tm1a
(KOMP)Wtsi or tm1a (EUCOMM)Wtsi] allele by creating and
analysing the derived deletion allele. This is a timely reminder,
with direct implications on the 3Rs, given the growing resource of
Figure 7. Normal phenotype observed in Slc25a21tm1b(KOMP)Wtsi, Slc25a21tm1c(KOMP)Wtsi and Slc25a21tm1d(KOMP)Wtsi homozygous mice. Body
weight and fat mass were normal in females homozygous (red symbols) for Slc25a21tm1b(KOMP)Wtsi (A,D) (n = 7), Slc25a21tm1c(KOMP)Wtsi (B,E) (n = 7), and
Slc25a21tm1d(KOMP)Wtsi mice (C,F) (body weight n = 7, fat mass n = 5) compared to local wild-type controls run on the same week (green symbols)
(n$9). Male homozygotes for each of these three alleles and two parameters were also phenotypically normal (data not shown). Mean (6 SD) body
weight is plotted against age (A–C). Fat mass is presented as a boxplot, with median, 25th and 75th percentile (box), and the lowest and highest data
point within 1.56 inter quartile range (whiskers) shown (D–F). The median and 95% reference range (2.5–97.5th percentiles, dotted lines) for all wild-
type mice of the same genetic background and sex (n.80) are displayed on the pale green background. ABR thresholds were normal in homozygous
Slc25a21tm1b(KOMP)Wtsi (G), Slc25a21tm1c(KOMP)Wtsi (H) and Slc25a21tm1d(KOMP)Wtsi mice (I) (red symbols) compared to wild-type controls (green symbols).
doi:10.1371/journal.pone.0091807.g007
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knockout first conditional ready targeted ES cells created by the
EUCOMM and KOMP initiatives.
Hypomorphic expression of Pax9 may account for
orofacial abnormalities
The Pax family of transcription factors plays a pivotal role in
embryonic patterning and disease. The expression of each Pax
gene is highly regulated in a temporal and spatial manner [30].
During mouse embryogenesis, Pax9 is expressed mainly in the
sclerotome of somites, the pharyngeal pouch endoderm and its
derivatives, developing limb buds, and in facial mesenchyme of
neural-crest cell origin, including nasal and jaw processes and
tooth buds [26,31]. There is strong expression of Pax9 in the
medial edge epithelium during the critical time points of palate
fusion [32]. In adult mice, Pax9 is expressed in oesophagus and
tongue [33]. Looking at published models of Pax9 deficiency,
homozygous Pax9 knockout mice die shortly after birth and exhibit
a wide range of developmental defects [26] including the absence
of teeth. Death has been attributed to cleft palate, affecting the
maxillary and palatine shelves, resulting in an inability to suckle
and respiratory issues [26]. Two hypomorphic alleles of Pax9 have
been published previously [25]. The first, which expressed wild-
type Pax9 mRNA at 7% of control levels, presented with
hypoplastic upper incisors lacking enamel, missing lower incisors,
unilateral or bilateral absence of the third molar in the upper jaw
and the second and third molar in the lower jaw, and the lower
molars that were present showed severe attrition. In comparison,
the hypomorphic allele with 20% of wild-type Pax9 mRNA
expression relative to controls presented with less severely affected
dentition including relatively normal upper incisors, hypoplastic
lower incisors lacking enamel and unilateral or bilateral absence of
the upper and lower third molar. We now report homozygous
Slc25a21tm1a(KOMP)Wtsi mice which express wild-type Pax9 mRNA
at 34% of control levels and present with an even milder dental
phenotype including upper incisors that were commonly maloc-
cluded, which may be due to abnormal snout morphology or the
fact that the incisors do not wear against each other. We found
fragile, damaged or missing lower incisors which were white or
translucent; normally incisors in mice are brownish/yellow due to
incorporation of iron-containing pigment in the enamel [34]. The
lower incisor root area was severely under-developed. Lower jaw
molars showed focal fracturing of the surface dentine and necrosis
of the pulp with associated inflammation and bacterial accumu-
lation. The presence of lacZ activity within the cavities of the lower
molars of homozygous Slc25a21tm1a(KOMP)Wtsi mice but not
heterozygous mice, confirms that bacterial b-galactosidase is the
cause of the staining, not expression of the lacZ reporter gene
within the targeted allele. Molars in the upper jaw were less
affected. The more severe findings in the lower jaw are consistent
with findings in the other Pax9 hypomorphic alleles [25].
Only limited assessment of the palate has been published for the
previous Pax9 hypomorphic lines and no abnormalities were
reported [25]. In this study, more extensive analysis was
performed and whilst the phenotype was significantly less severe
than that reported in Pax9 null mice [26], abnormalities were
identified, characterised largely by discordance of rugae 3 and an
incomplete fusion of the vomer bone to the maxilla.
This gradated allelic series of Pax9 expression levels, extended
by the data reported herein, clearly demonstrates that dosage of
this gene affects orofacial development and that lower jaw
dentition in the mouse is more susceptible to reduced Pax9
expression [25]. This is consistent with humans where dentition is
not uniformly affected by a reduced Pax9 expression [35,36,37]
and the observation that the minimal Pax9 gene dosage required
for the formation of individual teeth varies, the posterior tooth in
each tooth family being the most sensitive to a reduction in Pax9
levels.
Otitis media and hearing impairment in mice may be due
to disrupted Pax9 expression
A reduction in the size of the tympanic ring has previously been
described in Pax9 mutant mice [26], however the effect on hearing
has not previously been assessed. The homozygous Slc25a21tm1a(-
KOMP)Wtsi mice have a normal sized tympanic ring but display a
clear hearing impairment with increased thresholds at all
frequencies tested. The moderate hearing impairment seen in
homozygous Slc25a21tm1a(KOMP)Wtsi mice is robust and reproducible
across different cohorts of mice, tested at ages from 4 to 26 weeks
of age. The degree of impairment in mutant mice is progressive
from 4–14 weeks old, with slower progression to 26 weeks of age.
The parallel shifts in audiometric profiles across frequencies at the
different ages (Fig. 4) are consistent with an underlying conductive
hearing loss. Middle ears of the majority of homozygous
Slc25a21tm1a(KOMP)Wtsi mice were filled with fluid of varying
viscosity at all ages examined and sections revealed inflammation
of the lining of the middle ear. The presence of eosinophilic
exudate and the thickening of the mucosa are evident in the
homozygous Slc25a21tm1a(KOMP)Wtsi mice, indicating an on-going
inflammatory process. Whilst the aetiology of otitis media is
complex [38] and was beyond the scope of this study, the
correlation between signs of otitis media and elevated ABR
thresholds supports our suggestion that the otitis media is a major
contributor to the hearing impairment observed in the young adult
homozygous Slc25a21tm1a(KOMP)Wtsi mice. However, cochlear dys-
function cannot be ruled out especially in the 26 week-old group of
both mutants and controls. ABR data from Slc25a21tm1b(KOMP)Wtsi,
Slc25a21tm1c(KOMP)Wtsi and Slc25a21tm1d(KOMP)Wtsi homozygotes in-
dicate that hearing thresholds are normal.
Conclusion
In conclusion, ablation of Slc25a21 expression was not found to
phenocopy the human disease 2-oxoadipate acidaemia (OMIM
204750) for which it is a candidate gene. The phenotypes observed
Figure 8. RNA expression of Pax9 was reduced in Slc25a21tm1a(-
KOMP)Wtsi mice. Quantitative PCR on RNA from E13.5 embryo heads
demonstrated that Pax9 RNA expression was significantly reduced in
Slc25a21tm1a(KOMP)Wtsi (*** p = 1.1E-06) homozygotes, but equivalent to
wild-type levels in Slc25a21tm1b(KOMP)Wtsi, Slc25a21tm1c(KOMP)Wtsi and
Slc25a21tm1d(KOMP)Wtsi homozygotes.
doi:10.1371/journal.pone.0091807.g008
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in mice homozygous for Slc25a21tm1a(KOMP)Wtsi were not due to
ablation of Slc25a21 function, but instead the presence of the
selection cassette affected expression of the neighbouring gene,
Pax9. The resulting mutant line confirmed and extended the
existing knowledge of Pax9 gene dosage effect on orofacial
development and represents a novel model of otitis media that
may be due to reduced Pax9 expression.
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Figure S1 Ensembl view of 1 Mb genomic interval
encompassing Pax9 and Slc25a21. Ensembl view of the
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